subject area of
- Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin Journal Article
- Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms Journal Article
- Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA Journal Article
- EXPERIMENTAL CHEMOTHERAPY-INDUCED SKIN NECROSIS IN SWINE - MECHANISTIC STUDIES OF ANTHRACYCLINE ANTIBIOTIC TOXICITY AND PROTECTION WITH A RADICAL DIMER COMPOUND Journal Article
- Epidoxoform: A hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells Journal Article
- Growth inhibition, nuclear uptake, and retention of anthracycline-formaldehyde conjugates in prostate cancer cells relative to clinical anthracyclines Journal Article
- Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells - Inhibition of glutathione S-transferase P1-1 by glutathione conjugates from anthracyclines Journal Article
- Mass spectrometric measurement of formaldehyde generated in breast cancer cells upon treatment with anthracycline antitumor drugs Journal Article
- Methods to Characterize the Effect of DNA-Modifying Compounds on Nucleosomal DNA Journal Article
- Multistep Drug Intercalation: Molecular Dynamics and Free Energy Studies of the Binding of Daunomycin to DNA Journal Article
- Nuclear targeting and retention of anthracycline antitumor drugs in sensitive and resistant tumor cells Journal Article
- Production of formaldehyde and DNA-adriamycin or DNA-daunomycin adducts, initiated through redox chemistry of dithiothreitol/iron, xanthine oxidase/NADH/iron, or glutathione/iron Journal Article
- REDOX CHEMISTRY OF ANTHRACYCLINE ANTITUMOR DRUGS AND USE OF CAPTODATIVE RADICALS AS TOOLS FOR ITS ELUCIDATION AND CONTROL Journal Article
- Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin Journal Article
- Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer Therapy Journal Article